Matt Seefeld
Founder & CEO · Advisor · Investor
Revenue cycle automation is still a buzzword.
You can’t train AI to get claims paid if you never recorded why they weren’t.
Payers are investing heavily in AI to deny claims. Providers answer with people and, increasingly, bots, but rarely record why a claim was touched or whether that touch, human or AI, ever led to payment. For more than 20 years, I’ve designed and built systems that capture that missing layer, so AI and the people working alongside it can focus on the right claims and learn what gets paid on first submission and, when it doesn’t, trace the breakdown to where it started, often upstream, before care was ever delivered.
Founder, Chairman & Chief Executive Officer
Interpoint Partners
Founded 2007 · Acquired by Streamline Health, 2011
EVP & Chief Commercialization Officer
MedEvolve
Built the Effective Intelligence (Ei) platform · 2019–2025
Chief Executive Officer
MedEvolve
2025–2026 · Led the sale of the technology company and the RCM services business
Trained in management consulting · 2000–2006
Stockamp & Associates (now Huron) · PricewaterhouseCoopers · Deloitte Consulting
25+
Years building healthcare technology companies and revenue cycle operations
25+
EHR and practice management systems integrated
50+
On-stage talks, podcasts and bylined articles on revenue cycle, AI and healthcare business
Frequent speaker at MGMA · HBMA · HFMA · HIMSS · AAOE · ASOA
ABOUT
A 25-year pursuit of one question
More than twenty years ago, in a New York hotel room, I asked a question that has shaped my career: why can’t we see every touch it takes to get paid for care delivered?
After starting in consulting at Stockamp (now Huron), PwC and Deloitte, I turned that question into Interpoint Partners, a workflow automation and analytics company I founded and led as CEO through its sale to Streamline Health in 2011. At MedEvolve, I led the team that built the Effective Intelligence (Ei) platform. At both companies, our teams built financial clearance tools that caught eligibility and prior authorization problems before care was delivered, which lowered clients’ cost to collect. As CEO I led two transactions in 2025: the sale of the RCM services business, then the sale of the technology company to Emergence, backed by The Pritzker Organization.
Along the way I’ve worked with hundreds of health systems, RCM and BPO companies, practices and the private equity sponsors who back them. Today I advise and invest across healthcare technology and tech-enabled services. I’m based in San Diego.
HOW I HELP
Operating partner, board advisor and executive for healthcare companies at every stage, from first product to exit. Let’s talk →
01
Operating partner & board advisory
Diligence, value creation, bolt-ons and M&A for investors and boards in healthcare technology and services, deepest in revenue cycle.
02
Getting ready to sell
For sponsor-owned RCM and BPO companies and physician groups: an assessment and action plan to cut cost and wasted touches, find fast margin and set the M&A strategy, including combining overlapping companies into one stronger platform, so the business sells at a better valuation.
03
Breaking through the stall
From a pre-revenue idea, to a company stuck at $1–5M in ARR, to a larger business losing ground: a hands-on review of the product, integrations, vendor dependencies, sales cycle and competitive position to grow ARR, reduce churn and raise NPS.
04
Executive leadership
CEO and C-suite roles across product, commercialization, strategy and customer success, including turnarounds. Especially for tech vendors that also own RCM services: use AI to improve the product faster, then sell services to tech-only clients, cut churn and win new bookings.
05
Selling into healthcare
I’ve taken incubated ideas with no clients, brand or marketing into health systems, practices and RCM companies, then grown those accounts and won new logos. Many newly funded AI companies underestimate how hard that path is. I help them navigate it.
06
Customer success starts at the sale
Subject matter expertise built into sales, onboarding and implementation, so clients see the promised ROI and stay.
PERSPECTIVE
Everyone wants to automate how providers get paid. Almost no one can connect the systems to do it. Without interoperability across EHRs, vendors and payers, most revenue cycle bolt-ons can’t scale, and the ones that survive will be few and far between.
01
Status, action, payment
Capture every touch, human or AI, and classify it with a status more specific than the vague, often misleading 835 codes: what’s really wrong, the action taken, and whether payment followed before the next touch. That’s the only way to know which work gets claims paid.
02
Commodity data builds no moat
Everyone is grabbing the same claims and 835 data, so no one can innovate on it. The edge is touch-level data fed back upstream to predict and prevent denials, cut rework, and carve out the 78–85% of touches that never drive payment.
03
Keep humans in the loop, and measure them
Automate redundant administrative work freely. For work that should drive payment, automate only where the outcome proves it. Then measure people objectively, such as who gets paid on the first touch and who takes ten, so you can recognize, reward and keep your best.
04
People, process or technology?
When a claim doesn’t pay, the touch tells you something went wrong, but not where. Was it human behavior, a broken process, or technology that wasn’t implemented, configured or used correctly? Many denials trace back to registration, eligibility, prior authorization or coding, long before anyone works the AR. Most systems can’t tell the difference, so organizations buy more technology for what is often a people or process problem.
05
No interoperability where the money is
To run one bolt-on, vendors fight for minimum datasets, integrate with EHR companies that may compete with them, and depend on payers who may or may not cooperate. No one, including the government, is making this a priority. EHRs compete on clinical features, physician preference and patient engagement, not on whether providers get paid, so switching systems rarely fixes the revenue cycle. A great patient experience means little if the practice can’t stay open to deliver it. That’s why so few bolt-ons will scale.
06
Margin protects access
Reimbursement keeps falling, more of the bill shifts to patients who can’t pay up front, and the cost of delivering care keeps rising. Rural hospitals are closing, physician groups are breaking apart, and doctors are retiring early. A few points of margin decide who stays open.
SPEAKING & WRITING
Invited for the honest version. For more than a decade, I’ve been asked onto the main stages at the country’s largest healthcare conferences, onto podcasts and into print because I say what many won’t: healthcare’s financial model is in serious trouble, no single vendor will fix it, and waiting for payers, providers and patients to suddenly align isn’t a plan.
2026: The Year for Sunsetting Old-Guard Revenue Cycle Metrics
Physicians Practice · 2026. Why the metrics the revenue cycle has relied on for decades no longer tell leaders what they need to know, and what should replace them.
Rising Pressures on Rural Care
11Alive Atlanta · June 2026. The financial pressures pushing hospitals toward closure, and why administrative waste is part of the problem.
Is the Healthcare System Quietly Falling Apart?
Late Night Health Radio, iHeart · April 2026. An unfiltered conversation on wasted touches, payer-provider misalignment, and who ends up paying for it.
INVESTMENTS & ADVISORY
CureMetrix
Investor & Advisor. AI for mammography and breast imaging.
HealthQRS
Founding Seed Investor & Advisor. A cloud platform that brings retail-style price transparency, payment and navigation to the patient experience. Invested 2014.
Analytics Ventures
Venture Partner, 2014–2023. Invested alongside the fund in its portfolio companies.
MedPilot
Advisor to the Founder/CEO and executive team. A patient financial engagement platform that used machine learning to personalize billing outreach and help patients resolve medical bills. Acquired by Vytalize Health (2021).
CureMatch
Strategic Advisor. AI-driven decision support that helps oncologists choose personalized combination therapies for each patient’s cancer.